Senseonics Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
4.2%projected annual EPS growth
Analyst Coverage
5analysts covering
FY Revenue (est.)
$62.2Mnext fiscal year
FY EPS (est.)
-$2.45next fiscal year
Monitoring Framework
Key Performance Indicators
Global Net Revenue Quarterly11.7MTarget: 60000000 to 64000000
Full Year Gross Margin Annually58.0%Target: 55 to 58%
Watch Items
- Transition of European sales and marketing infrastructure from AscensiaTrigger: Completion of local asset purchase agreements in key EU marketsAction: Verify closing of local asset purchases in Germany, Spain, Sweden, and Italy to bring commercialization fully in-house.
- Gemini Pivotal Trial ProgressTrigger: Completion of the trial in the second half of 2026Action: Monitor clinical trial updates and preparation for regulatory submissions to support the planned Q2 2027 launch.
Research as of 20 Jun 2026